Afekta Technologies
Metabolomics analysis of microbial and plant compounds for food manufacturers and academic researchers
Highlights
- New on EvolcAdded 2026-10-28
About Afekta Technologies
Afekta Technologies provides metabolomics services, measuring small molecules in biological samples with LC-MS. Its Microbolome service analyses microbial metabolites, Fytovore measures phytochemicals in plant-based foods, and custom metabolomics profiling covers any biological sample. The company also offers an untargeted lipidomics analysis covering major lipid classes and lipophilic phytochemicals.
Customers include food manufacturers, and industrial and academic research groups that need metabolomics for R&D or research projects. The company sells its analyses as services and provides reports beyond raw data.
Afekta was founded in 2017 and is headquartered in Kuopio, Finland. Its team includes scientists with backgrounds in nutrition, pharmacology, analytical chemistry and molecular medicine. It has also hosted doctoral fellows through the EU-funded HoloGen Marie Skłodowska-Curie Doctoral Network.
Product: Metabolomics analysis services: Microbolome (microbial metabolites), Fytovore (phytochemicals in food), custom metabolomics profiling and untargeted lipidomics.
Jobs at Afekta Technologies
Leadership
- Kati Hanhineva · Person who brought Afekta into life; Professor of Food Development and group leader in nutritional metabolomicsSource: company website
- Olli Kärkkäinen · CEOSource: company website
- Ville Koistinen · Chief Operating OfficerSource: company website
More biotech & pharma companies
Amitav
Research-grade chemicals and custom synthesis for academic, pharma and biotech labs, with global shippingNew on EvolcAq Biotech
Develops phage-based biosensor diagnostics for early disease detection and monitoring from non-invasive biological samplesYoung companyNew on EvolcAranda Pharma
Develops drug candidates for people with hair loss, acne and brain diseasesNew on EvolcAurealis
Develops bacterial gene therapies for patients with chronic wounds, cancer and inflammatory diseasesNew on EvolcAurlide
Drug discovery services for pharma teams: virtual screening for first hits, hit-to-lead optimization and pharmacokinetics toolsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cookiebot
- Google Ads
- Google Tag Manager
- WordPress
- jQuery
- nginx